SIX Swiss Exchange · Healthcare
Invest in Galenica stock from India
Indian and foreign residents can buy Galenica (GALE) shares directly through Paasa.
By Paasa · Updated
Galenica at a glance
- Price
- CHF 82.35-CHF 0.25 (0.30%)
- Market cap
- CHF 4.10B
- Day range
- CHF 82.15 – CHF 82.80
- P/E
- 25.80
- Dividend yield
- 3.04%
- Volume
- 9.59K
- 1 month
- -2.37%
- 6 months
- -7.05%
- YTD
- -16.31%
- 1 year
- -3.80%
- 5 years
- +26.01%
Galenica statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 4.1B | CHF 3.9B | CHF 3.7B | CHF 4.0B | CHF 3.8B |
| Gross profit | CHF 428.8M | CHF 1.1B | CHF 387.6M | CHF 374.1M | CHF 350.5M |
| Operating income | CHF 222.8M | CHF 204.4M | CHF 191.3M | CHF 193.0M | CHF 186.3M |
| Net income | CHF 181.1M | CHF 183.0M | CHF 173.6M | CHF 165.1M | CHF 167.7M |
| Earnings per share | CHF 3.63 | CHF 3.67 | CHF 5.72 | CHF 3.32 | CHF 3.38 |
| EBITDA | CHF 339.2M | CHF 331.3M | CHF 306.9M | CHF 290.5M | CHF 300.3M |
| Total assets | CHF 3.3B | CHF 3.1B | CHF 3.0B | CHF 2.7B | CHF 2.6B |
| Total debt | CHF 1.1B | CHF 775.6M | CHF 236.0M | CHF 686.5M | CHF 672.6M |
| Cash and short-term investments | CHF 115.5M | CHF 129.7M | CHF 116.2M | CHF 93.9M | CHF 165.0M |
| Shareholders' equity | CHF 1.5B | CHF 1.5B | CHF 1.5B | CHF 1.2B | CHF 1.2B |
| Operating cash flow | CHF 299.8M | CHF 264.7M | CHF 225.7M | CHF 236.9M | CHF 333.1M |
| Free cash flow | CHF 272.4M | CHF 192.3M | CHF 149.3M | CHF 166.5M | CHF 273.0M |
| Capital expenditure | −CHF 27.4M | −CHF 72.4M | −CHF 76.4M | −CHF 70.4M | −CHF 60.1M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Ypsomed | YPSN.SW | CHF 366.60 | CHF 4.82B |
| Siegfried | SFZN.SW | CHF 74.50 | CHF 3.26B |
| Tecan | TECN.SW | CHF 236.00 | CHF 2.99B |
| BB Biotech | BION.SW | CHF 51.40 | CHF 2.83B |
| Medacta | MOVE.SW | CHF 117.00 | CHF 2.33B |
| SKAN | SKAN.SW | CHF 68.80 | CHF 1.55B |
| Cosmo Pharmaceuticals | COPN.SW | CHF 58.70 | CHF 1.01B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Galenica from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search GALE and buy
Find Galenica by name or by its ticker, GALE, and place your order.
Why invest in Galenica from India
What Galenica does
Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Galenica operates in the Medical - Distribution industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Galenica stock from India?
Yes. Indian residents and NRIs can buy Galenica (GALE) shares directly through Paasa. Galenica is listed on the SIX Swiss Exchange, in the Medical - Distribution industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Galenica shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.